2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Antigens: new trials by email Literature Review of Antigens trials Research Report on Antigens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer Celecoxib, Durvalumab, Tremelimumab - Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | Phase 2 | Recruiting | Emory University | 39 | 2026-01-02 | 2026-01-28 |
| A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older Low dose antigen and low dose adjuvant of LYB004, Low dose antigen and high dose adjuvant of LYB004, High dose antigen and low dose adjuvant of LYB004 - Herpes Zoster (HZ), Shingles | Phase 2 | Active not recruiting | Guangzhou Patronus Biotech Co., Ltd. | 840 | 2025-10-23 | 2025-12-30 |
| Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer Autologous dendritic cells pulsed with antigen - NSCLC | Phase 1 / Phase 2 | Unknown | Henan Cancer Hospital | 30 | 2019-12-01 | 2019-12-16 |
| Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL TVGV-1, GPI-0100, Placebo - Human Papillomavirus, High-Grade Squamous Intraepithelial Lesions | Phase 2 | Unknown | THEVAX Genetics Vaccine | 10 | 2015-11-01 | 2017-10-25 |
| Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) Whole virion, Vero cell-derived influenza vaccine containing either 3.75 µg or 7.5 µg H5N1 hemagglutinin (HA) antigen in a non-adjuvanted formulation - Influenza | Phase 1 / Phase 2 | Completed | Alachua Government Services, Inc. | 110 | 2007-07-01 | 2015-10-09 |
Carcinoma, Hepatocellular (1) · Chickenpox (1) · Herpes Zoster (1) · Influenza, Human (1) · Squamous Intraepithelial Lesions (1) · Uterine Cervical Dysplasia (1)
Alachua Government Services, Inc. (1) · Emory University (1) · Guangzhou Patronus Biotech Co., Ltd. (1) · Henan Cancer Hospital (1) · THEVAX Genetics Vaccine (1)
China (2) · United States (2) · Hong Kong (1) · Singapore (1)
Frank L Douglas, PhD, MD (1) · Olumide B. Gbolahan, MBBS, MSc (1) · Tao Huang (1) · Zibing Wang (1)
P30CA138292 (1)